MedTrace Logo

Non-invasive Measurement of Glucose with Advanced Spectroscopy Techniques and Machine Learning Models

NCT06406075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2025-03-10

No results posted yet for this study

Summary

Primary aim of this pilot study is to provide evidence for a non-invasive, continuous, and transcutaneous measurement method to determine blood glucose levels robustly and accurately.

Conditions

  • Healthy

Interventions

DEVICE

Lab demo 1.0

During the intervention, transcutaneous spectral data are collected continuously with the Lab demo. Up to 20 whole blood glucose reference values are also collected, as well as interstitial fluid glucose values using a continuous glucose monitoring device. Some participants will attend multiple measurement sessions.

Sponsors & Collaborators

  • Liom Health AG

    lead INDUSTRY

Principal Investigators

  • Fabien Rebeaud, PhD · Liom Health AG

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2024-10-25
Completion
2024-10-25

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06406075 on ClinicalTrials.gov